Pfizer beats out Novo in bidding war for obesity-drug startup Metsera

Pfizer has won the bidding war against Novo Nordisk to acquire obesity-drug biotech Metsera.

The pharma giant upped its offer, valuing the startup at up to around $10 billion, Metsera said Friday.

Read the rest…

​STAT Pharma: The science and business of new drug development

Leave a Reply

Your email address will not be published. Required fields are marked *